Treatment Patterns and Outcomes in Unresectable or Metastatic Renal Cell Carcinoma (mRCC) Patients in Japan
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 297
- 试验地点
- 1
- 主要终点
- Treatment patterns
研究概览
简要总结
A medical review chart study in Japan to describe the treatment patterns and outcomes of patients with kidney cancer that is unable to be removed by surgery or that has spread. The clinical data is to be abstracted using electronic data capture (eDC) from patient medical records in Japan.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 20 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adults 20 years and older at the time of initial diagnosis of mRCC
- •Alive or deceased as of the date of data collection
- •Diagnosis of mRCC between 01-Jan-2012 and 31-Aug-2015
排除标准
- •Previously and/or currently enrolled in RCC clinical trials
- •Patients have primary cancer other than renal cell cancer
结局指标
主要结局
Treatment patterns
时间窗: Approximately 5 years
measured by retrospective data collection of treatment regimen and duration (including rate of permanent and temporary discontinuation)
Reason for terminating or switching treatment
时间窗: Approximately 5 years
measured by data collection information available in retrospective analysis, if disclosed
Adverse Events
时间窗: Approximately 5 years
measured by data collection
Overall survival
时间窗: Approximately 2 years
measured by data collection in years
次要结局
未报告次要终点